Giacomo Maria Cioffi, Pablo Lamelas, Mariam Shenouda, Jamie Halperin, Francesca Goffredo, Brian Patrick McGrath, Norman Said Vega Servin, Shamir R Mehta, Sanjit S Jolly, J D Schwalm, Madhu K Natarajan, Nicholas Valettas, James L Velianou, Michael B Tsang, Natalia Pinilla-Echeverri, Matthew G Sibbald, Tej N Sheth
{"title":"OCT-based diagnosis, management, and predictors of recurrent stent failure: a cohort study.","authors":"Giacomo Maria Cioffi, Pablo Lamelas, Mariam Shenouda, Jamie Halperin, Francesca Goffredo, Brian Patrick McGrath, Norman Said Vega Servin, Shamir R Mehta, Sanjit S Jolly, J D Schwalm, Madhu K Natarajan, Nicholas Valettas, James L Velianou, Michael B Tsang, Natalia Pinilla-Echeverri, Matthew G Sibbald, Tej N Sheth","doi":"10.3389/fcvm.2025.1565676","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Stent failure (SF) is a complication of percutaneous coronary intervention (PCI).</p><p><strong>Objectives: </strong>This study aimed to assess the relationship of the optical coherence tomography (OCT) determined cause of SF with time since stent implantation, treatment, and outcome.</p><p><strong>Methods: </strong>This retrospective study included patients who underwent an OCT evaluation for SF from January 2013 to July 2023. In-stent findings were evaluated on OCT including tissue proliferation, tissue type, underexpansion, thrombus, and multiple stent layers. The relationship between time to presentation, treatment, and outcome was assessed.</p><p><strong>Results: </strong>Of the 309 patients who underwent an OCT-guided PCI for SF, tissue proliferation was present in 228 (74%) and absent in 81 (26%). Among patients with tissue proliferation, OCT commonly showed lipidic neointima (<i>n</i> = 122, 54%), thrombus (<i>n</i> = 81, 36%), and underexpansion (<i>n</i> = 71, 31%). In patients without tissue proliferation, OCT commonly identified underexpansion (<i>n</i> = 58, 72%), thrombus (<i>n</i> = 55, 68%), and uncovered struts (<i>n</i> = 37, 46%). The mean time to SF was 6.89 ± 5.88 years with tissue proliferation and 2.98 ± 3.75 years without (<i>p</i> < 0.001). Patients with tissue proliferation were more likely to be treated with repeat stenting (78% vs. 60%, <i>p</i> < 0.001). Lipidic neointimal tissue and >1 layer of stent were predictors of target SF recurrence during a median 3 years of follow-up.</p><p><strong>Conclusion: </strong>In a large series of OCT-guided treatments of SF, tissue proliferation was more common, occurred later after stent implantation, and was more likely to be treated with repeat stenting than no-tissue proliferation. Lipidic neointimal tissue and >1 layer of stent were significant predictors of target SF during follow-up.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"12 ","pages":"1565676"},"PeriodicalIF":2.8000,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12106419/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Cardiovascular Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fcvm.2025.1565676","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Stent failure (SF) is a complication of percutaneous coronary intervention (PCI).
Objectives: This study aimed to assess the relationship of the optical coherence tomography (OCT) determined cause of SF with time since stent implantation, treatment, and outcome.
Methods: This retrospective study included patients who underwent an OCT evaluation for SF from January 2013 to July 2023. In-stent findings were evaluated on OCT including tissue proliferation, tissue type, underexpansion, thrombus, and multiple stent layers. The relationship between time to presentation, treatment, and outcome was assessed.
Results: Of the 309 patients who underwent an OCT-guided PCI for SF, tissue proliferation was present in 228 (74%) and absent in 81 (26%). Among patients with tissue proliferation, OCT commonly showed lipidic neointima (n = 122, 54%), thrombus (n = 81, 36%), and underexpansion (n = 71, 31%). In patients without tissue proliferation, OCT commonly identified underexpansion (n = 58, 72%), thrombus (n = 55, 68%), and uncovered struts (n = 37, 46%). The mean time to SF was 6.89 ± 5.88 years with tissue proliferation and 2.98 ± 3.75 years without (p < 0.001). Patients with tissue proliferation were more likely to be treated with repeat stenting (78% vs. 60%, p < 0.001). Lipidic neointimal tissue and >1 layer of stent were predictors of target SF recurrence during a median 3 years of follow-up.
Conclusion: In a large series of OCT-guided treatments of SF, tissue proliferation was more common, occurred later after stent implantation, and was more likely to be treated with repeat stenting than no-tissue proliferation. Lipidic neointimal tissue and >1 layer of stent were significant predictors of target SF during follow-up.
期刊介绍:
Frontiers? Which frontiers? Where exactly are the frontiers of cardiovascular medicine? And who should be defining these frontiers?
At Frontiers in Cardiovascular Medicine we believe it is worth being curious to foresee and explore beyond the current frontiers. In other words, we would like, through the articles published by our community journal Frontiers in Cardiovascular Medicine, to anticipate the future of cardiovascular medicine, and thus better prevent cardiovascular disorders and improve therapeutic options and outcomes of our patients.